Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo
- PMID: 17178763
- PMCID: PMC1798420
- DOI: 10.1136/ard.2006.055541
Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).Arthritis Rheum. 2005 Apr;52(4):1227-36. doi: 10.1002/art.20967. Arthritis Rheum. 2005. PMID: 15818699 Clinical Trial.
-
Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.Clin Rheumatol. 2007 Jul;26(7):1132-3. doi: 10.1007/s10067-006-0422-z. Epub 2006 Aug 19. Clin Rheumatol. 2007. PMID: 16924391 No abstract available.
-
Long term treatment of psoriatic arthritis with infliximab.Ann Rheum Dis. 2004 Nov;63(11):1531-2; author reply 1532. Ann Rheum Dis. 2004. PMID: 15479917 Free PMC article. No abstract available.
-
Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.Ann Rheum Dis. 2002 Apr;61(4):298-304. doi: 10.1136/ard.61.4.298. Ann Rheum Dis. 2002. PMID: 11874829 Free PMC article. Review.
-
TNFalpha inhibition in psoriatic arthritis: cause for hope.Joint Bone Spine. 2001 Mar;68(2):106-8. doi: 10.1016/s1297-319x(01)00257-3. Joint Bone Spine. 2001. PMID: 11324924 Review. No abstract available.
Cited by
-
Long-term remission and biologic persistence rates: 12-year real-world data.Arthritis Res Ther. 2021 Jan 13;23(1):25. doi: 10.1186/s13075-020-02380-z. Arthritis Res Ther. 2021. PMID: 33441191 Free PMC article.
-
Measuring Outcomes in Psoriatic Arthritis.Arthritis Care Res (Hoboken). 2020 Oct;72 Suppl 10(Suppl 10):82-109. doi: 10.1002/acr.24242. Arthritis Care Res (Hoboken). 2020. PMID: 33091263 Free PMC article. Review. No abstract available.
-
Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.Arthritis Res Ther. 2011 Jan 27;13(1):R7. doi: 10.1186/ar3228. Arthritis Res Ther. 2011. PMID: 21272347 Free PMC article. Clinical Trial.
-
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare.Int J Immunopathol Pharmacol. 2016 Jun;29(2):252-66. doi: 10.1177/0394632015593220. Epub 2015 Dec 18. Int J Immunopathol Pharmacol. 2016. PMID: 26684633 Free PMC article.
-
What does evidence-based medicine tell us about treatments for different subtypes of psoriatic arthritis? A systematic literature review on randomized controlled trials.Rheumatol Adv Pract. 2018 Jan 8;2(1):rkx019. doi: 10.1093/rap/rkx019. eCollection 2018. Rheumatol Adv Pract. 2018. PMID: 31431950 Free PMC article.
References
-
- Gladman D D, Helliwell P, Mease P J, Nash P, Ritchlin C, Taylor W. Assessment of patients with psoriatic arthritis: a review of currently available measures. Arthritis Rheum 20045024–35. - PubMed
-
- Dougados M, Gueguen A, Nakache J P, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 198815302–307. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical